CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.85B, above the global median of $1.18B
- PositionReturn on equity is -33%, lower than 95% of its Medical Instruments & Supplies peers (median 5.9%)
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
6.90%Above 5Y avg (2.41%)
Annual Rate
USD 0.64Paid quarterly
Payout Ratio
28.8%Sustainable
Paying Dividends
22 yr
Payback Period
13.5 yr
Last Ex-Dividend
Dec 26, 2025
Last Payment
Jan 9, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.85BUSDvs all stocks (USD)
Revenue (TTM)
3.64BUSDvs all stocks (USD)
Profit Margin
-14.99%vs Medical Instruments & Supplies peers
Beta
0.8500xvs all stocks
52-Week Change
-26.41%vs all stocks
Forward Annual Dividend Yield
6.90%vs all stocks
Market Capitalization
1.85BUSDvs all stocks (USD)
Enterprise Value
3.96BUSDvs all stocks (USD)
Forward P/E
6.23xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
0.5144xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.43xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.09xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
7.53xvs Medical Instruments & Supplies peers
Gross Margin
54.90%vs Medical Instruments & Supplies peers
Profit Margin
-14.99%vs Medical Instruments & Supplies peers
Operating Margin
9.24%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.96%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-33.03%vs Medical Instruments & Supplies peers
Revenue (TTM)
3.64BUSDvs all stocks (USD)
Revenue per Share (TTM)
18.24USDUpdated Sep 29, 2026Quarterly Revenue Growth
-4.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.80BUSDvs all stocks (USD)
EBITDA (TTM)
530.00MUSDvs all stocks (USD)
Net Income (TTM)
-546.00MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-4.06%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
319.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
141.62MUSDvs all stocks (USD)
Forward Annual Dividend Rate
0.6400USDUpdated Sep 29, 2026Forward Annual Dividend Yield
6.90%vs all stocks
Trailing Annual Dividend Rate
0.6400USDUpdated Sep 29, 2026Trailing Annual Dividend Yield
6.90%vs all stocks
5-Year Average Dividend Yield
2.41%vs all stocks
Payout Ratio
28.83%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
1.00MUSDFY2025 · Dec 31, 2025Revenue
3.68BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.84BUSDFY2025 · Dec 31, 2025Gross Profit
1.84BUSDFY2025 · Dec 31, 2025Operating Income
252.00MUSDvs all stocks (USD)
Pre-tax Income
-486.00MUSDFY2025 · Dec 31, 2025Income Tax Expense
112.00MUSDFY2025 · Dec 31, 2025Net Income
-598.00MUSDFY2025 · Dec 31, 2025EBIT
-398.00MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
596.00MUSDFY2025 · Dec 31, 2025Research & Development
150.00MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
1.44BUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
88.00MUSDFY2025 · Dec 31, 2025EPS (Basic)
-3.00USDFY2025 · Dec 31, 2025EPS (Diluted)
-3.00USDFY2025 · Dec 31, 2025Basic Shares Outstanding
199.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
199.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-598.00MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
-334.00MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
326.00MUSDFY2025 · Dec 31, 2025Income Tax Paid
71.00MUSDFY2025 · Dec 31, 2025Interest Paid
66.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-598.00MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
352.00MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
30.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
33.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-10.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-91.00MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
11.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-61.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
-14.00MUSDFY2025 · Dec 31, 2025Sale of Investments
10.00MUSDFY2025 · Dec 31, 2025Other Investing Activity
3.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.00MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
553.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-918.00MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-336.00MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
0.00USDFY2025 · Dec 31, 2025Common Dividends Paid
-128.00MUSDFY2025 · Dec 31, 2025Other Financing Charges
-22.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-851.00MUSDFY2025 · Dec 31, 2025Shares Outstanding
199.20MSharesUpdated Sep 29, 2026Float Shares
187.87MSharesUpdated Sep 29, 2026Shares Short
24.59MSharesUpdated Sep 29, 2026Short Ratio
6.96daysvs all stocks
Short % of Shares Outstanding
13.76%vs all stocks
% Held by Insiders
0.65%vs all stocks
% Held by Institutions
117.88%vs all stocks
Total Cash (MRQ)
239.00MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.20USDUpdated Sep 29, 2026Total Debt (MRQ)
2.33BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.72xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.63xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.58USDUpdated Sep 29, 2026Total Assets
5.43BUSDvs all stocks (USD)
Total Current Assets
2.02BUSDFY2025 · Dec 31, 2025Total Liabilities
4.09BUSDFY2025 · Dec 31, 2025Total Non-current Assets
3.41BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
2.75BUSDFY2025 · Dec 31, 2025Total Current Liabilities
1.34BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
326.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
688.00MUSDFY2025 · Dec 31, 2025Inventory
642.00MUSDFY2025 · Dec 31, 2025Accounts Payable
300.00MUSDFY2025 · Dec 31, 2025Short-term Debt
360.00MUSDFY2025 · Dec 31, 2025Deferred Revenue
74.00MUSDFY2025 · Dec 31, 2025Other Current Liabilities
30.00MUSDFY2025 · Dec 31, 2025Long-term Debt
2.11BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
544.00MUSDFY2025 · Dec 31, 2025Common Stock (Book)
3.00MUSDFY2025 · Dec 31, 2025Retained Earnings
-1.56BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.34BUSDvs all stocks (USD)
Treasury Stock
3.10BUSDFY2025 · Dec 31, 202552-Week Low
8.90USDUpdated Sep 29, 202652-Week High
14.76USDUpdated Sep 29, 202652-Week Change
-26.41%vs all stocks
Beta
0.8500xvs all stocks
50-Day MA
11.59USDUpdated Sep 29, 2026200-Day MA
11.67USDUpdated Sep 29, 2026Avg 10-Day Volume
5.52MSharesUpdated Sep 29, 2026Avg 30-Day Volume
4.13MSharesUpdated Sep 29, 2026Diluted EPS (TTM)
-2.73USDUpdated Sep 29, 2026Other Income / Expense
-650.00MUSDFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Return on equity is -33%, lower than 95% of its Medical Instruments & Supplies peers (median 5.9%)Significant
Return on equity: -0.33Industry median: 0.06Industry P5: -0.24Peers compared: 38.00
Debt-to-equity is 1.72×, higher than 95% of its Medical Instruments & Supplies peers (median 0.16×)Significant
Debt-to-equity: 1.72Industry median: 0.16Industry P95: 1.01Peers compared: 38.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.55Profit Margin: -0.15
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.63Altman Z-Score: 0.45
Financial Health
Altman Z-Score 0.45: distress zoneCritical
Altman Z-Score: 0.45
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.85B, above the global median of $1.18BNotable
Market cap (USD): 1,850,003,969Global Median: 1,180,223,658.953
Revenue is $3.64B, above the global median of $548.88MNotable
Revenue (USD): 3,643,000,064Global Median: 548,883,780.48
Levered free cash flow is $141.62M, above the global median of $18.73MNotable
Levered free cash flow (USD): 141,624,992Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Expro Group Holdings N.V.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
F&F Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowAttention
Guangdong Guanghua Sci-Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Beijing Aerospace Shenzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangsu Cnano Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shandong Pharmaceutical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Willfar Information Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Shenzhen Qingyi Photomask Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Dn Automotive Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sichuan Jiuzhou Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Wuzhou Special Paper Group Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
Sunwoda Electronic Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators
Wonders Information Co., Ltd.
2 interpretationsWithin or Near the Altman Distress ZoneElevated Leverage on Three Denominators